3 12 This finding contrasts with a significant trend in treating younger patients in the USA. 10 However, it is consistent with evidence from the FRANCE 2 TAVI registry that reported an unchanged median age (83 years (IQR 79, 87)) of patients treated between 2010 and 2021. 1 13 14 In addition, we found no significant changes in the operative risk (STS score and EuroSCORE II) of patients undergoing TAVI over time.
← all excerpts
Trends in transcatheter aortic valve implantation practice and clinical outcomes at an Irish tertiary referral centre.
1
—
—